OA. However, injection schedules, injection sites, and comparators have varied substantially between trials. This treatment has not been evaluated in hand OA and, therefore, no recommendation is made with regard to OA of the hand. Platelet-rich plasma treatment is strongly recommended against in patients with knee and/or hip OA. In contrast to intraarticular therapies discussed above, there is concern regarding the heterogeneity and lack of standardization in available preparations of